Physician profile
Paul Miller
NPI 1568777282
$32,339.93
in general payments reported to CMS, 2019-2025
10 companies · $5,077 in 2025
The $5,077 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $235 · 2021: $2,798 · 2022: $3,855 · 2023: $14K · 2024: $5,709 · 2025: $5,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $1,883 · Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,684.30 |
| Travel and Lodging | $1,882.74 |
| Food and Beverage | $1,554.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $24,884.37 | 2023-2025 | Regatta Lateral System, Miscellaneous, Manta Ray |
| Seaspine Orthopedics Corporation | $5,683.65 | 2020-2022 | |
| Medtronic, INC. | $1,150.76 | 2021-2023 | Mazor X System, Stealthstation S8 Platform, Prestige LP Cervical Disc System |
| Medtronic USA, INC. | $324.92 | 2019-2020 | |
| Depuy Synthes Sales INC. | $103.76 | 2019-2020 | |
| Globus Medical, INC. | $58.94 | 2021-2022 | |
| Providence Medical Technology, INC. | $52.25 | 2025 | |
| Brainlab, INC. | $51.50 | 2019 | |
| Glaxosmithkline, LLC. | $16.44 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.34 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.